I think the fact that many posters might be long term holders , is little irrelevant to the discussion per se .
I'm guessing most are long term holders , because they see the potential value proposition in the science IMU have .
Certainly many may not understand it ..... however IF you do frankly its very compelling .
I mean take the B Cell platform as an example
> apparently same or better Efficacy than SoC
> apparently a far less invasive treatment regime
> potentially far less costly
> potentially opens up treatment to millions ( and Governments and Insurance companies would love this ) - the IP is "out of left field " ....but looks like its starting to get an ever-growing following
I wont even discuss the other two but there is plenty of info in the public domain
https://www.imugene.com/
IF something works , and the need is there , as well as the ability to deliver ...then looking at potential value propositions is quite reasonable
I added the CSL screenshot ( and I know - totally differnt animals in that CSL had a long established business with Cash Flow ) ...I suppose as much to point out that here is a company that has increased its market cap by some 100 times over the years . ( & who would have thought that possible back in the day )
Getting back to IMU - IF the IP does start to infiltrate ...then theres every reason to assume some fairly bullish estimate of likely value .
What is extremely evident ( particularly from someone who has followed the evolution of IMU ) is that may of the people who " bag the stock " - and we see the same names this morning , clearly have very very little knowledge of what IMU are doing .
Any way stand by for the unfolding story of IMU .
cheers
- Forums
- ASX - By Stock
- IMU
- IMU Target $2.00 - Not Ramping !!!
IMU
imugene limited
Add to My Watchlist
18.2%
!
1.3¢

IMU Target $2.00 - Not Ramping !!!, page-91
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M |
Open | High | Low | Value | Volume |
1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 5795292 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 3258567 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 5735292 | 0.012 |
35 | 10497532 | 0.011 |
118 | 35980571 | 0.010 |
37 | 19431668 | 0.009 |
13 | 4220748 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 3078567 | 8 |
0.014 | 10063029 | 39 |
0.015 | 6593187 | 20 |
0.016 | 6224494 | 27 |
0.017 | 7006978 | 10 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online